Zobrazeno 1 - 10
of 13
pro vyhledávání: '"E V, Semaeva"'
Autor:
M. I. Voevoda, Yu. I. Ragino, A. M. Chernyavsky, S. Yu. Tsymbal, E. V. Semaeva, Ya. V. Polonskaya, M. V. Ivanova
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 1, Pp 65-69 (2010)
In 42-70-year-old Siberian men with coronary atherosclerosis, verified by coronary angiography, the prevalence of metabolic syndrome (MS) was as high as 89%, which suggests an important role of MS in atherosclerosis development in the Siberian region
Externí odkaz:
https://doaj.org/article/348947e03a034b709b63d9ed4df793bf
Autor:
Yu. I. Ragino, A. M. Chernyavsky, A. V. Tikhonov, S. Yu. Tsymbal, Ya. V. Polonskaya, E. V. Semaeva, M. V. Ivanova, M. I. Voevoda
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 31-35 (2009)
Blood lipid (total cholesterol (CH), triglycerides, low and high-density lipoprotein CH (LDL-CH, HDL-CH), lipoprotein (a)) and non-lipid (high-sensitive C-reactive protein (hsCRP), homocysteine, interleukins (IL) beta, 6, and 8, tumor necrosis factor
Externí odkaz:
https://doaj.org/article/47a8c3adb67040d69266581d9e55dfa2
Autor:
M. I. Voevoda, E. V. Semaeva, Yu. I. Ragino, S. K. Malutina, M. V. Ivanova, A. M. Chernyavsky
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 58-62 (2005)
The article is devoted to the diagnostics of lipid and lipoprotein disturbances in coronary atherosclerosis among Novosibirsk City males, comparing to general population. The study included 392 males aged 35-70 years. The main group consisted of 87 p
Externí odkaz:
https://doaj.org/article/0ee7453b1cc2463e8b214982d56109a6
Autor:
Ya. V. Polonskaja, Yu. I. Ragino, E. V. Kashtanova, E. V. Semaeva, D. A. Redjkin, A. M. Chernjavski, S. Yu. Tchimbal, Mikhail I. Voevoda
Publikováno v:
Bulletin of Experimental Biology and Medicine. 149:587-590
In male patients with coronary atherosclerosis without acute coronary syndrome, the levels of inflammatory-destructive biomarkers of atherosclerotic plaque instability depended on the severity and dissemination of coronary atherosclerosis. The highes
Autor:
Iu I, Ragino, A M, Cherniavskiĭ, Ia V, Polonskaia, A M, Volkov, E V, Semaeva, S Iu, Tsymbal, M I, Voevoda
Publikováno v:
Kardiologiia. 49(6)
We studied men with coronary atherosclerosis without acute coronary syndrome and determined typical valuable parameters of inflammatory (tumor necrotic factor, antagonist of receptor to interleukin [IL] 1, IL 6, IL 8, monocytes chemotactic protein 1,
Autor:
A. M. Volkov, E. V. Semaeva, Ya. V. Polonskaya, Mikhail I. Voevoda, Yu. I. Ragino, A. M. Chernyavski
Publikováno v:
Bulletin of experimental biology and medicine. 144(5)
Oxidative and antioxidant parameters (content of LPO products and oxidized proteins, initial level of paraoxonase, content of alpha-tocopherol, retinol, and beta-carotene) were studied at different stages of atherosclerotic foci development in corona
Publikováno v:
Kardiologiia. 47(9)
We studied parameters of inflammatory (tumor necrosis factor a, antagonist of interleukin-1 receptor, interleukin-6 , interleukin-8, C-reactive protein) and destructive (matrix metalloproteinases type 3 and 9, tissue inhibitor of metalloproteinase ty
Autor:
Iu I, Ragino, Ia V, Polonskaia, E V, Semaeva, E V, Kashtanova, I V, Kulikov, A M, Cherniavskiĭ, M I, Voevoda
Publikováno v:
Kardiologiia. 47(11)
We studied parameters of structural and oxidative modification of low density lipoproteins (LDL) in 80 men aged 35 - 65 years with coronary atherosclerosis verified at coronary angiography in comparison with 80 men of the same age without ischemic he
Autor:
M I, Voevoda, S N, Ustinov, N S, Yudin, M M, Dolgikh, T N, Kuznetsova, V N, Maksimov, I V, Kulikov, A A, Gromov, A V, Shabalin, E V, Semaeva, V F, Kobzev, S R, Baum, V V, Gafarov, S K, Malyutina, A G, Romaschenko, YuP, Nikitin
Publikováno v:
Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections. 385
Autor:
S. Tcimbal, E. V. Semaeva, Y.V. Polonskaja, A. M. Volkov, Yu. I. Ragino, M I Voevoda, A.M. Chernjavski
Publikováno v:
Atherosclerosis Supplements. 11:7-8